S S Burtles
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
Papers in
-
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Surgery 4
- Co-authors
- Ruth Duncan (2 shared papers)T. E. Hilditch (1 shared paper)T. Murray (1 shared paper)Peter D. Wilson (1 shared paper)J Cassidy (1 shared paper)Daniela Fraier (1 shared paper)E. Frigerio (1 shared paper)Stan B. Kaye (1 shared paper)
- Journals
- British Journal of Cancer (4 papers)Immunology Letters (1 paper)Human & Experimental Toxicology (1 paper)The Journal of Immunology (1 paper)European Journal of Immunology (1 paper)
- Partner nations
- United KingdomItalyBelgium
In The Last Decade
S S Burtles
17 papers receiving 1.2k citations
S S Burtles's Hit Papers
Peers
Comparison fields: 5 of 91
- Biomaterials 598
- Pharmaceutical Science 52
- Biomedical Engineering 334
- Polymers and Plastics 106
- Oncology 179
Countries citing papers authored by S S Burtles
This map shows the geographic impact of S S Burtles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Burtles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Burtles more than expected).
Fields of papers citing papers by S S Burtles
This network shows the impact of papers produced by S S Burtles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Burtles. The network helps show where S S Burtles may publish in the future.
Co-authors
The 25 scholars most cited alongside S S Burtles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Hit paper breakdown → | 1999 | 627 |
| 2 | 2002 | 250 | |
| 3 | Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. | 1992 | 69 |
| 4 | 1998 | 63 | |
| 5 | 1999 | 53 | |
| 6 | 1994 | 37 | |
| 7 | 2004 | 19 | |
| 8 | 1992 | 16 | |
| 9 | 1993 | 14 | |
| 10 | 2002 | 13 | |
| 11 | 2003 | 12 | |
| 12 | 1984 | 11 | |
| 13 | 1990 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 2003 | 4 | |
| 16 | The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes. | 1992 | 4 |
| 17 | 1992 | 1 |
About S S Burtles
S S Burtles is a scholar working on Immunology, Surgery, Oncology, Genetics and Biomaterials, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (4 papers), Cancer Treatment and Pharmacology (4 papers), Diabetes and associated disorders (3 papers), Immunotherapy and Immune Responses (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Diabetes Treatment and Management (2 papers), Computational Drug Discovery Methods (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Biomaterials (598 citations), Pharmaceutical Science (52 citations), Biomedical Engineering (334 citations), Polymers and Plastics (106 citations) and Oncology (179 citations). S S Burtles has collaborated with scholars based in United Kingdom, Italy and Belgium. Frequent co-authors include Ruth Duncan, T. E. Hilditch, T. Murray, Peter D. Wilson, J Cassidy, Daniela Fraier, E. Frigerio, Stan B. Kaye, Alison H. Thomson and Chris Twelves. Their work appears in journals such as British Journal of Cancer, Immunology Letters, Human & Experimental Toxicology, The Journal of Immunology and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.